How Many Temporomandibular Joint Total Joint Alloplastic Implants Will Be Placed in the United States in 2030?

Publication date: Available online 23 April 2016
Source:Journal of Oral and Maxillofacial Surgery
Author(s): Uvoh Onoriobe, Michael Miloro, Cortino Sukotjo, Louis G. Mercuri, Anthony Lotesto, Ransome Eke
PurposeThe purpose of this study is to provide a statistical projection of the number of alloplastic temporomandibular joint total joint replacements (TMJ TJR) that will be performed in the United States (USA) through the year 2030.Materials and MethodsThe Program Directors of all 101 Commission on Dental Accreditation (CODA) accredited oral and maxillofacial surgery (OMS) training programs in the USA were surveyed on-line using a questionnaire developed using Redcap (Chicago, IL) over a 6-week period (February 2015 – March 2016). The questionnaire included 19 questions related to each program's temporomandibular joint disorders (TMD) and TMJ TJR curricula as well as clinical experience. In addition, members of the American Society of TMJ Surgeons (ASTMJS) were surveyed on-line using Redcap and via direct survey forms. In addition, requests for the total number of TMJ TJR devices produced and implanted during the same time period were made to the three manufacturers of FDA-approved TMJ TJR devices in the USA.ResultsThe response rate amongst Program Directors was 52.5%, and the total number of TMJ TJR devices implanted at OMS programs in 2005 was 412. This total increased by 38% to 572 in 2014. Statistically, this projects an increase of 58% over the next 15 years to 902 TMJ TJR surgeries by 2030 (95% prediction limits: 768, 1,037). The total number TMJ TJR devices distributed by one manufacturer increased from 430 in the year 2000, to 1,004 in 2014 (133%). Using these data, statistically over the next 15 years the number of TMJ TJR devices distributed by this company is projected be 1,658 (95% prediction limits: 1,380, 1,935).ConclusionsThe data presented in this study demonstrates an increasing demand for the use of TMJ TJR devices in the management of end-stage TMD to the year 2030.



from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/1Tp0UkF
via IFTTT